BSX vs CRDO · P/E 20, rev $10.65B vs P/E 308, rev $1.34B
Boston Scientific Corp (BSX) versus Credo Technology Group Holding Ltd (CRDO) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Credo Technology Group Holding Ltd (CRDO) is a semiconductors company listed on US.
Latest reported BSX revenue for 2026-06-30 was $10.65B. Net income was $2.24B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported CRDO revenue for 2026-05-02 was $1.34B. Net income was $472.3M. Revenue was up 205.7% from 2025-05-03 to 2026-05-02. CRDO currently screens at market cap $15.34B and trailing P/E 308.2.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. CRDO currently screens at market cap $15.34B and trailing P/E 308.2.
Not investment advice. Open the BSX and CRDO stock pages for the full models.
Not investment advice.